155 related articles for article (PubMed ID: 9158812)
21. Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin.
Lund B; Adamsson I; Edlund C
Int J Food Microbiol; 2002 Jul; 77(1-2):109-15. PubMed ID: 12076027
[TBL] [Abstract][Full Text] [Related]
22. Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
Herrera-Insúa I; Jacques-Palaz K; Murray BE; Rakita RM
Antimicrob Agents Chemother; 1996 Apr; 40(4):886-90. PubMed ID: 8849245
[TBL] [Abstract][Full Text] [Related]
23. Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.
Robredo B; Singh KV; Torres C; Murray BE
Microb Drug Resist; 2000; 6(4):305-11. PubMed ID: 11272259
[TBL] [Abstract][Full Text] [Related]
24. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control.
Deplano A; Denis O; Nonhoff C; Rost F; Byl B; Jacobs F; Vankerckhoven V; Goossens H; Struelens MJ
J Antimicrob Chemother; 2007 Oct; 60(4):849-54. PubMed ID: 17650516
[TBL] [Abstract][Full Text] [Related]
25. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci.
Rice LB; Hutton-Thomas R; Lakticova V; Helfand MS; Donskey CJ
J Infect Dis; 2004 Mar; 189(6):1113-8. PubMed ID: 14999616
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
Kim YR; Kim SI; Hur JA; Kim YJ; Wie SH; Park YJ; Kang MW
Ann Clin Lab Sci; 2007; 37(3):260-2. PubMed ID: 17709691
[TBL] [Abstract][Full Text] [Related]
27. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Lorian V; Fernandes F
Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.
Ray AJ; Pultz NJ; Bhalla A; Aron DC; Donskey CJ
Clin Infect Dis; 2003 Oct; 37(7):875-81. PubMed ID: 13130397
[TBL] [Abstract][Full Text] [Related]
29. Intestinal Enterococcus faecium colonization improves host defense during polymicrobial peritonitis.
Leendertse M; Willems RJ; Oei GA; Florquin S; Bonten MJ; van der Poll T
J Infect Dis; 2009 Sep; 200(5):735-44. PubMed ID: 19604046
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
31. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model.
Rice LB; Lakticová V; Carias LL; Rudin S; Hutton R; Marshall SH
J Infect Dis; 2009 Feb; 199(3):342-9. PubMed ID: 19049434
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of vancomycin-resistant Enterococcus faecium (VREF) in pig faeces from slaughterhouses in Spain.
Herrero IA; Teshager T; Garde J; Moreno MA; Domínguez L
Prev Vet Med; 2000 Dec; 47(4):255-62. PubMed ID: 11087956
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
Yoon YK; Lee SE; Lee J; Kim HJ; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2011 Aug; 66(8):1831-8. PubMed ID: 21652622
[TBL] [Abstract][Full Text] [Related]
34. [Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs].
Inoue M; Kubo S; Saito A; Ubukata K; Shimizu Y; Igari J; Watanabe A; Oguri T; Kawai T; Kobayashi Y; Hayashi M; Shiba K; Sakamoto M; Kanno H; Tokue Y; Yamaguchi K; Miyazaki S; Higashitsutsumi M; Sakamoto M; Inamatsu T; Kohno S; Tomono K; Shimada J; Kaku M; Ueda Y
Jpn J Antibiot; 1999 Apr; 52(4):302-12. PubMed ID: 10396687
[TBL] [Abstract][Full Text] [Related]
35. Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.
Sahgal VS; Urban C; Mariano N; Weinbaum F; Turner J; Rahal JJ
Microb Drug Resist; 1995; 1(3):245-7. PubMed ID: 9158782
[TBL] [Abstract][Full Text] [Related]
36. Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure.
Millichap J; Ristow TA; Noskin GA; Peterson LR
Diagn Microbiol Infect Dis; 1996 May; 25(1):15-20. PubMed ID: 8831040
[TBL] [Abstract][Full Text] [Related]
37. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
Donskey CJ; Hanrahan JA; Hutton RA; Rice LB
J Infect Dis; 2000 May; 181(5):1830-3. PubMed ID: 10823795
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
39. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
Werner G; Klare I; Spencker FB; Witte W
J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
[TBL] [Abstract][Full Text] [Related]
40. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization.
Webb M; Riley LW; Roberts RB
Clin Infect Dis; 2001 Aug; 33(4):445-52. PubMed ID: 11462178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]